Haroutunian V - Search Results

1

Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain.

Scheckel C, Drapeau E, Frias MA, Park CY, Fak J, Zucker-Scharff I, Kou Y, Haroutunian V, Ma'ayan A, Buxbaum JD, Darnell RB. Scheckel C, et al. Among authors: haroutunian v. Elife. 2016 Feb 19;5:e10421. doi: 10.7554/eLife.10421. Elife. 2016. PMID: 26894958 Free PMC article.

2

Intraneuronal Abeta42 accumulation in human brain.

Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR. Gouras GK, et al. Among authors: haroutunian v. Am J Pathol. 2000 Jan;156(1):15-20. doi: 10.1016/s0002-9440(10)64700-1. Am J Pathol. 2000. PMID: 10623648 Free PMC article.

3

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Näslund J, et al. Among authors: haroutunian v. JAMA. 2000 Mar 22-29;283(12):1571-7. doi: 10.1001/jama.283.12.1571. JAMA. 2000. PMID: 10735393

4

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.

Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS, Pasinetti GM. Ho L, et al. Among authors: haroutunian v. Arch Neurol. 2001 Mar;58(3):487-92. doi: 10.1001/archneur.58.3.487. Arch Neurol. 2001. PMID: 11255454

5

Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.

Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC, Park H, Moran TM, Chan JY, Buxbaum JD. Parvathy S, et al. Among authors: haroutunian v. Arch Neurol. 2001 Dec;58(12):2025-32. doi: 10.1001/archneur.58.12.2025. Arch Neurol. 2001. PMID: 11735776

6

Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.

Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Hof PR, et al. Among authors: haroutunian v. Neurochem Res. 2002 Oct;27(10):1193-200. doi: 10.1023/a:1020981510759. Neurochem Res. 2002. PMID: 12462417

7

White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. Davis KL, et al. Among authors: haroutunian v. Arch Gen Psychiatry. 2003 May;60(5):443-56. doi: 10.1001/archpsyc.60.5.443. Arch Gen Psychiatry. 2003. PMID: 12742865 Review.

8

Altered Abeta formation and long-term potentiation in a calsenilin knock-out.

Lilliehook C, Bozdagi O, Yao J, Gomez-Ramirez M, Zaidi NF, Wasco W, Gandy S, Santucci AC, Haroutunian V, Huntley GW, Buxbaum JD. Lilliehook C, et al. Among authors: haroutunian v. J Neurosci. 2003 Oct 8;23(27):9097-106. doi: 10.1523/JNEUROSCI.23-27-09097.2003. J Neurosci. 2003. PMID: 14534243 Free PMC article.

9

Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype.

Causevic M, Ramoz N, Haroutunian V, Davis KL, Buxbaum JD. Causevic M, et al. Among authors: haroutunian v. J Neuropathol Exp Neurol. 2003 Oct;62(10):999-1005. doi: 10.1093/jnen/62.10.999. J Neuropathol Exp Neurol. 2003. PMID: 14575236

10

Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.

Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, Williams J, Buckland PR, Owen MJ, O'Donovan MC. Bray NJ, et al. Among authors: haroutunian v. Hum Mol Genet. 2004 Nov 15;13(22):2885-92. doi: 10.1093/hmg/ddh299. Epub 2004 Sep 22. Hum Mol Genet. 2004. PMID: 15385439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters